Emmes

Join Our Team at Emmes! Are you ready to take the next step in your career? We are actively hiring for multiple exciting roles across various expertise areas. If you're passionate, talented, and ready to make an impact, check out our open positions: Location: Bangalore (Hybrid) Why Join Emmes? ?Work with a team of experts dedicated to innovation and excellence ?Tackle impactful projects in technology, data science, and AI ?Grow your skills and career in a dynamic, supportive environment visit https://lnkd.in/gDQu763r to explore our open roles and apply today! #Hiring #JobOpportunities #AIJobs #DataScienceJobs #Innovation #CareerGrowth #Emmes?#MachineLearning #DeepLearning #DataScienceJobs #DataScientist #Analytics?#DataEngineering #TechLeadership #Innovation #ExecutiveJobs #Leadership ?#TMFSpecialist #ClinicalResearchJobs #ClinicalOperations #SASJobs #StatisticalProgramming #TMFLead #ClinicalResearch #ClinicalDocumentation #ClinicalTrials Dhana lakshmi Ganga Ashok Neeta Nimbark Archana Sarda Narasimha Rao AyyalasomayajulaNatesh BhargavKarunakar ReddyMurali MuppireddySubhrajit GhoseRajaram VenkatesanKushal D RSagar Sutar Manjunath ShanabagFahd Khan

We are excited to announce that Emmes has co-authored three oral abstracts for the upcoming 66th American Society of Hematology Annual Meeting! In addition to these three, Emmes is proud to work alongside the BMT CTN and National Institutes of Health to exhibit additional poster presentations such as: ?? The Composite Health Risk Assessment Model (CHARM) Predicts Risks of Toxicities, Functional and Cognitive Decline Among Survivors of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): A Prospective BMT-CTN Study 1704, Mohamed Sorror, MD MSc ?? Likelihood of finding an 8/8 HLA-matched unrelated donor (Donor Search Prognosis) is not associated with survival: Primary results from BMT CTN 1702, Stephanie Lee, MD, MPH ?? Uncovering the Tumor Antigen Landscape in Patients Undergoing Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance Treatment [BMT CTN 1401] Dimitra Karagkouni, PhD To learn more about the life-changing work that Emmes is a part of, visit us at booth #145. #Hematology #CROPartner #ASH2023 #celltherapy #genetherapy #sicklecell

Psychedelics like MDMA, psilocybin, and ketamine are revolutionizing mental health treatment, showing potential for PTSD, depression, and substance use disorders. But as Steffanie Wilson, PhD highlights in this recent European Pharmaceutical Review article, the FDA rejection of Lykos Therapeutics' MDMA therapy underscores the need for rigorous clinical trial designs and a more adaptive regulatory framework. The path forward demands innovation and evidence-driven solutions to ensure safe, effective, and accessible treatments for mental health. In this article, Steffanie discusses: - How psychedelics promise rapid therapeutic benefits, while proving consistent and lasting efficacy. - Challenges in navigating the FDA's drug-focused approval processes, particularly for drug-therapy combinations. - Funding from NIDA for psychedelics research reflecting growing federal support. ?? What do you see as the biggest challenge or opportunity for psychedelics in mental health treatment? Click here to read more: https://hubs.la/Q02Z3M3t0 #PsychedelicTherapy #ClinicalResearch #MentalHealthInnovation #EmmesGroup

Looking forward to the ASH Annual Meeting and Exposition? Stop by booth# 145 to chat with our team of experts. With over three decades of leadership in Cell and Gene Therapy research, Emmes is ready to help you navigate the complexities of clinical trials. Meet our experts to learn how we can accelerate your next study. Book a meeting here: https://lnkd.in/gbbiEU9x Adam Mendizabal, Victoria Coleman-Cowger, Denise King, Jennifer Romeril, Natalia de Val, Jenna Cohen McGuirk, Karen Stablein, Anthony Arrigo #GeneTherapy #ClinicalResearch #ClinicalTrials #Emmes #CellandGeneTherapy #CRO #ASHAnnualMeeting

???Empowering the Next Generation of Women in STEM! ?? Last week, as part of our Emmes Cares program, our team had the incredible opportunity to contribute to and participate in STEM for Her Day. This hands-on, conference-style event brought together 300 female high school students from the DC Metro area for a day full of inspiration and empowerment! ?? The event featured four exciting tracks – Science, Technology, Engineering, and Math – where students had the chance to engage with industry professionals, explore career opportunities, and gain valuable insights into university options. ???? #EmmesCares #WomenInSTEM #ClinicalResearch

Interested in leading innovative Neuroscience clinical research? Emmes is hiring a Project Leader with NeuroHIV experience to support one of our longest-running Neuroscience clinical research efforts, the Data Coordinating Center for the National NeuroHIV Tissue Consortium. Learn more about this exciting opportunity and how to apply: https://hubs.la/Q02Ydl9d0 #Emmes #Hiring #ProjectManager #ClinicalTrials #NeuroHIV

In Cell and Gene Therapy (CGT) clinical trials, missing data is a critical risk, not just an inconvenience. At Emmes, we specialize in tackling this challenge with innovative strategies, from optimized trial design to regulatory approval. We guide sponsors every step of the way, ensuring data integrity and accelerating success. Discover how Emmes can help you navigate these complexities and achieve successful trials. #CellTherapy #GeneTherapy #Biotech #ClinicalTrials #ClinicalResearch #DataIntegrity

At Emmes, we’re transforming the future of cell and gene therapy! With over 20 years of partnership with the NIH and established connections to more than 100 blood and marrow transplantation centers, we’re at the forefront of advancing innovative treatments. Our team specializes in handling the complexities of patient pathways, overlapping endpoints, and small patient populations—ensuring that every step in the journey is backed by expertise. Plus, with our tech and AI-enabled capabilities, we’re leveraging automated document generation, protocol digitization, track-and-trace technology, and centralized monitoring to create a seamless research experience from start to finish. To learn more or speak to an expert, schedule a meeting here: https://hubs.la/Q02X0cLG0 #CellTherapy #GeneTherapy #Biotech #ClinicalResearch

We are proud to share the wonderful recognition "Gold Star Award" that the NEIS team received from the The National Institutes of Health IRBO. The NEIS team proactively ensured that the National Eye Institute (NEI)'s protocols are compliant with current regulations and policies over this year. This is truly a testament to the effort and high-quality work put forth by the team as they collaborated across 30+ protocols, multitude of investigators, ever changing regulatory guidance and landscape at the NIH. Congratulations to the team! Supriya Menezes, Audrey Hoppenjans MPS, CCRP, Jennifer Pilallis, Erika Dallmann, Samuel Chow, Grace John, and Alexandra Chang. https://hubs.la/Q02V-H7W0

Our team at Emmes Bangalore came together to celebrate Diwali in true festive spirit, with everyone dressed in beautiful ethnic wear, embracing the joy of togetherness and prosperity. From vibrant office decorations to sharing delicious sweets, every moment reflected the warmth of our workplace culture. This festival of lights reminds us of the bright opportunities ahead and the growth we’re building together. We extend our heartfelt thanks to our clients and sponsors for being part of our journey and for their continued trust and support. Let’s keep shining brightly and spreading positivity! As we look forward to new possibilities, we’re excited to invite talented, driven individuals to join our team. If you’re ready to make an impact, grow, and thrive in a dynamic environment, we’d love to hear from you! https://lnkd.in/eUwDesrw Wishing everyone a joyful and prosperous Diwali! #CRO #OfficeCelebration #TeamSpirit #techEnabledCRO Archana Sarda, Subhrajit Ghose, Karunakar Reddy, Pankaj Dua, Dr Arpit Agarwal, Narasimha Rao Ayyalasomayajula, Sandesh Nalawade Ph.D., MBA, PMP?, Rajaram Venkatesan, Sagar Sutar, Savitha P.L., Fahd Khan